From: Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
ncRNAs | Â | Change | Element affected | Consequence | References |
---|---|---|---|---|---|
MiRNAs | miR-212-3p | Down-regulation | Paclitaxel | Reduced ZEB2 level | [48] |
 | miR-106a | Down-regulation | Gemcitabine | Reduced PDGF-D/Twist1 pathway | [49] |
 | miR-9 | Down-regulation | Cisplatin | Reduced EIF5A2-mediated EMT | [50] |
 | miR-216a/217 | Up-regulation | Sorafenib | Induced SMAD7/TGF-β & PTEN/PI3K/Akt signaling | [51] |
LncRNAs | Linc-ROR | Up-regulation | Doxorubicin | Induced Twist1 level | [52] |
 | Lnc-H19 | Up-regulation | Sorafenib | Induced EMT via sponging miR-675 | [53] |
 | Lnc-POIR | Up-regulation | Sorafenib | Induced EMT via sponging miR-182-5p | [54] |
 | Lnc-SNHG3 | Up-regulation | Sorafenib | Induced EMT via miR-128/CD151 pathway | [55] |
 | Lnc-AOC4P | Down-regulation | EMT | Reduced vimentin level | [56] |
 | Linc-p21 | Down-regulation | EMT and lung metastasis | Inhibited Notch signaling | [57] |
CircRNAs | Circ_0003998 | Up-regulation | Doxorubicin | Induced EIF5A2-mediated EMT via sponging miR-218-5p | [58] |
 | CircFoxo3 | Up-regulation | Adriamycin | Induced ABCCA1-mediated EMT via sponging miR-199a-5p | [59] |